Publication | Closed Access

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study)

Antiretroviral-naïve PatientsSimilar Antiviral EfficacyAntiviral Drug DevelopmentAntiviral TherapyVirologyPharmacotherapyAntiviral DrugMedicineLake Study